Truitt RL, Johnson BD . Principles of graft-versus-leukemia reactivity Biol Blood Marrow Transplant 1995 1: 61–68 CASPubMed Google Scholar
Weiden PL, Sullivan KM, Flournoy N et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation New Engl J Med 1981 304: 1529–1533 ArticleCASPubMed Google Scholar
Gale RP, Champlin RE . How does bone-marrow transplantation cure leukaemia? Lancet 1984 2: 28–30 ArticleCASPubMed Google Scholar
Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75: 555–562 CASPubMed Google Scholar
Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 1990 76: 2462–2465 CASPubMed Google Scholar
Bar B, Schattenberg A, Mesnick E . Donor leukocyte infusions for chronic myeloid leukemia after allogeneic bone marrow transplantation J Clin Oncol 1993 11: 513–519 ArticleCASPubMed Google Scholar
Drobyski WR, Keever CA, Roth MS et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose Blood 1993 82: 2310–2318 CASPubMed Google Scholar
Porter DL, Roth MS, McGarigle C . Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia New Engl J Med 1994 330: 100–106 ArticleCASPubMed Google Scholar
Van Rhee F, Lin F, Cullis JO et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse Blood 1994 83: 3377–3383 CASPubMed Google Scholar
Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041–2050 CASPubMed Google Scholar
Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation Blood 1996 87: 2195–2204 CASPubMed Google Scholar
Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433–444 ArticlePubMed Google Scholar
Mehta J . The first clinical use of donor leukocyte infusions for the treatment of leukemia relapsing after allogeneic bone marrow transplantation Blood 1996 87: 4010–4023 CASPubMed Google Scholar
Ferster A, Bujan W, Mouraux T et al. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation Bone Marrow Transplant 1994 14: 331–332 CASPubMed Google Scholar
D'Hondt L, Chatelain C, Doyen C et al. Transient complete remission of acute lymphoblastic leukemia in relapse after allogeneic bone marrow transplantation induced by donor leukocyte transfusions Hematol Cell Ther 1996 38: 353–354 ArticleCASPubMed Google Scholar
Kawakami T, Umehara S, Fukunaga M et al. Grade IV graft-versus-host disease and a 1-year remission following donor leukocyte transfusion for treatment of relapsed acute lymphoblastic leukemia (letter) Bone Marrow Transplant 1996 17: 464–465 CASPubMed Google Scholar
Russell L, Jacobsen N, Heilmann C et al. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients Bone Marrow Transplant 1996 18: 411–414 CASPubMed Google Scholar
Saw M, Teh A, Wong H, Bosco J . Haematological remission induced by donor leukocyte infusion in a case of Philadelphia positive acute lymphoblastic leukaemia relapsing after allogeneic bone marrow transplantation Int J Hematol 1997 65: 173–178 ArticleCASPubMed Google Scholar
Yazaki M, Andoh M, Ito T et al. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion Bone Marrow Transplant 1997 19: 393–394 ArticleCASPubMed Google Scholar
Keil F, Kalhs P, Haas O et al. Relapse of a Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leukocytes Br J Haematol 1997 97: 161–164 ArticleCASPubMed Google Scholar
Atra A, Millar B, Shepherd V et al. Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation Br J Haematol 1997 97: 165–168 ArticleCASPubMed Google Scholar
Locatelli F, Comoli P, Giorgiani G et al. Infusion of donor-derived peripheral blood leukocytes after transplantation of cord blood progenitor cells can increase the graft-versus-leukaemia effect Leukemia 1997 11: 729–731 ArticleCASPubMed Google Scholar
Lawson S, Darbyshire P . Use of donor lymphocytes in extramedullary relapse of childhood acute lymphoblastic leukaemia following bone marrow transplantation Bone Marrow Transplant 1998 22: 829–830 ArticleCASPubMed Google Scholar
Berthou C, Leglise M, Herra A et al. Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia Leukemia 1998 12: 1676–1681 ArticleCASPubMed Google Scholar
Chang C, Lin S, Liu T et al. Donor leukocyte infusion as salvage therapy in an adult with relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation J Formos Med Assoc 1998 97: 55–58 CASPubMed Google Scholar
Glucksberg H, Storb R, Fefer A . Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304 ArticleCASPubMed Google Scholar
Shulman HM, Sullivan KM, Weiden PL . Chronic graft-vs.-host syndrome in man. A long-term clinicopathological study of 20 Seattle patients Am J Med 1980 69: 204–217 ArticleCASPubMed Google Scholar
Kaplan E, Meier P . Non-parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481 Article Google Scholar
Borgan, Liest'l K . A note on confidence intervals and bands for the survival curve based on transformations Scand J Stat 1990 17: 35–41 Google Scholar
Kolb H-J . Adoptive immunotherapy in chimeras for the treatment of leukemia. In: Perry MC (ed) American Society of Clinical Oncology Educational Book American Society of Clinical Oncology: Alexandria, VA 1999 pp.235–240 Google Scholar
Guinan EC, Gribben JG, Boussiotis VA et al. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity Blood 1994 84: 3261–3282 CASPubMed Google Scholar
Hirano N, Takahashi T, Takahashi T et al. Expression of costimulatory molecules in human leukemias Leukemia 1996 10: 1168–1176 CASPubMed Google Scholar
Freedman AS . Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas Semin Hematol 1993 30: 318–328 CASPubMed Google Scholar
Garrido F, Cabrera T, Concha A et al. Natural history of HLA expression during tumor development Immunol Today 1993 14: 491–499 ArticleCASPubMed Google Scholar
Cardoso A, Schultze J, Boussiotis V et al. Pre-B acutelymphoblastic leukemia cells may induce T-cell anergy to alloantigen Blood 1996 88: 41–48 CASPubMed Google Scholar
Riddell S, Greenberg P . Adoptive immunotherapy withantigen-specific T cells. In: Thomas E, Blume K, Forman S (eds) Hematopoietic Cell Transplantation, 2nd edn Blackwell Science: Malden, MA 1999 pp.327–341 Google Scholar